Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 103026, 8 pages
http://dx.doi.org/10.1155/2012/103026
Research Article

Validation of the Antiproliferative Effects of Organic Extracts from the Green Husk of Juglans regia L. on PC-3 Human Prostate Cancer Cells by Assessment of Apoptosis-Related Genes

Molecular Cancer Biology Research Laboratory (MCBRL), Department of Food Science and Nutrition, College of Food and Agricultural Sciences, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia

Received 31 May 2011; Revised 28 October 2011; Accepted 28 October 2011

Academic Editor: Vincenzo De Feo

Copyright © 2012 Ali A. Alshatwi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. El-Mesery, M. Al-Gayyar, H. Salem, M. Darweish, and A. El-Mowafy, “Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides,” Cell Division, vol. 4, article 6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Stampar, A. Solar, M. Hudina, R. Veberic, and M. Colaric, “Traditional walnut liqueur—cocktail of phenolics,” Food Chemistry, vol. 95, no. 4, pp. 627–631, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Oliveira, A. Sousa, I. Ferreira, A. Bento, L. Estevinho, and J. A. Pereira, “Total phenols, antioxidant potential and antimicrobial activity of walnut (Juglans regia L.) green husks,” Food and Chemical Toxicology, vol. 46, no. 7, pp. 2326–2331, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. K. J. Spaccarotella, P. M. Kris-Etherton, W. L. Stone et al., “The effect of walnut intake on factors related to prostate and vascular health in older men,” Nutrition Journal, vol. 7, no. 1, pp. 13–22, 2008. View at Google Scholar
  5. E. Daniel, A. S. Krupnick, Y. H. Heur, J. A. Blinzler, R. W. Nims, and G. D. Stoner, “Extraction, stability, and quantitation of ellagic acid in various fruits and nuts,” Journal of Food Composition and Analysis, vol. 2, no. 4, pp. 338–349, 1989. View at Google Scholar · View at Scopus
  6. B. Narayanan, O. Geoffroy, M. C. Willingham, G. Re, and D. Nixon, “p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells,” Cancer Letters, vol. 136, no. 2, pp. 215–221, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Labrecque, S. Lamy, A. Chapus et al., “Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound,” Carcinogenesis, vol. 26, no. 4, pp. 821–826, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Kris-Etherton, S. Yu-Poth, J. Sabaté, H. Ratcliffe, G. Zhao, and T. Etherton, “Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk,” American Journal of Clinical Nutrition, vol. 70, no. 3, pp. 504S–511S, 1999. View at Google Scholar · View at Scopus
  9. A. Chisholm, J. Mann, M. Skeaff et al., “A diet rich in walnuts favourably influences plasma fatty acid profile in moderately hyperlipidaemic subjects,” European Journal of Clinical Nutrition, vol. 52, no. 1, pp. 12–16, 1998. View at Google Scholar · View at Scopus
  10. M. Abbey, M. Noakes, G. Belling, and P. Nestel, “Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol,” American Journal of Clinical Nutrition, vol. 59, no. 5, pp. 995–999, 1994. View at Google Scholar · View at Scopus
  11. H. A. Mosli, “Prostate cancer in Saudi Arabia in 2002,” Saudi Medical Journal, vol. 24, no. 6, pp. 573–581, 2003. View at Google Scholar · View at Scopus
  12. Y. S. Pu, H. S. Chiang, C. C. Lin, C. Y. Huang, K. H. Huang, and J. Chen, “Changing trends of prostate cancer in Asia,” Aging Male, vol. 7, no. 2, pp. 120–132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Al-Hamdan, K. Ravichandran, J. Al-Sayyad et al., “Incidence of cancer in Gulf Cooperation Council countries, 1998–2001,” Eastern Mediterranean Health Journal, vol. 15, no. 3, pp. 600–611, 2009. View at Google Scholar
  14. Cancer Incidence Report, Saudi Arabia (1999-2000), National Cancer Registry, Ministry of Health, Kingdom of Saudi Arabia, 2004.
  15. H. A. Mosli, T. A. Abdel-Meguid, J. A. Al-Maghrabi, W. K. Kamal, H. A. Saadah, and H. M. Farsi, “The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients,” Saudi Medical Journal, vol. 30, no. 11, pp. 1439–1443, 2009. View at Google Scholar · View at Scopus
  16. S. Sowmyalakshmi, M. Nur-E-Alam, M. A. Akbarsha, S. Thirugnanam, J. Rohr, and D. Chendil, “Investigation on Semecarpus Lehyam—a Siddha medicine for breast cancer,” Planta, vol. 220, no. 6, pp. 910–918, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. R. Khan and S. M. Mlungwana, “γ-Sitosterol, a cytotoxic sterol from Markhamia zanzibarica and Kigelia africana,” Fitoterapia, vol. 70, no. 1, pp. 96–97, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. R. G. Panchal, “Novel therapeutic strategies to selectively kill cancer cells,” Biochemical Pharmacology, vol. 55, no. 3, pp. 247–252, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. T. N. Hasan, B. L. Grace, G. Shafi, A. A. Al-Hazzani, and A. A. Alshatwi, “Anti- proliferative effects of organic extracts from Root Bark of Juglans Regia L. (RBJR) on PC-3human breast cancer cells: role of Bcl-2/Bax, caspases and Tp53,” Asian Pacific Journal of Cancer Prevention, vol. 12, no. 2, pp. 525–530, 2011. View at Google Scholar
  20. R. James and S. Warburton, “Hemocytometer cell counts and viability studies: cell quantification,” in Cell and Tissue C ulture: Laboratory Procedures in Biotechnology, A. Doyle and J. Bryan Grifith, Eds., pp. 57–61, John Wiley & Sons, England, UK, 1st edition, 1999. View at Google Scholar
  21. J. Meenakshi, Anupama, S. K. Goswami, and K. Datta, “Constitutive expression of hyaluronan binding protein 1 (HABP1/p32/gC1qR) in normal Wbroblast cells perturbs its growth characteristics and induces apoptosis,” Biochemical and Biophysical Research Communications, vol. 300, pp. 686–693, 2003. View at Google Scholar
  22. A. A. Alshatwi, “Catechin hydrate suppresses MCF-7 proliferation through TP53/Caspase-mediated apoptosis,” Journal of Experimental & Clinical Cancer Research, vol. 17, no. 29, p. 167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Shafi, A. Munshi, T. N. Hasan, A. A. Alshatwi, A. Jyothy, and D. K. Y. Lei, “Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of Nigella sativa,” Cancer Cell International, vol. 9, article 29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. S. Yuan, A. Reed, F. Chen, and C. N. Stewart Jr., “Statistical analysis of real-time PCR data,” BMC Bioinformatics, vol. 7, article 85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. W. E. von Hardman and G. Ion, “Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut,” Nutrition and Cancer, vol. 60, no. 5, pp. 666–674, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. G. R. von Kiparski, L. S. Lee, and A. R. Gillespie, “Occurrence and fate of the phytotoxin juglone in alley soils under black walnut trees,” Journal of Environmental Quality, vol. 36, no. 3, pp. 709–717, 2007. View at Publisher · View at Google Scholar
  27. K. B. Aithal, M. R. Sunil Kumar, B. Nageshwar Rao, N. Udupa, and B. S. Satish Rao, “Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells,” Cell Biology International, vol. 33, no. 10, pp. 1039–1049, 2009. View at Publisher · View at Google Scholar
  28. Y. B. Ji, Z. Y. Qu, X. Zou, L. Cui, and G. J. Hu, “Growth inhibition and induction of apoptosis in sarcoma 180 cells by Juglone in vivo,” in Proceedings of the International Seminar on Future BioMedical Information Engineering (FBIE '08), pp. 325–328, December 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. G. T. Williams and C. A. Smith, “Molecular regulation of apoptosis: genetic controls on cell death,” Cell, vol. 74, no. 5, pp. 777–779, 1993. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Marzo and J. Naval, “Bcl-2 family members as molecular targets in cancer therapy,” Biochemical Pharmacology, vol. 76, no. 8, pp. 939–946, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. H. K. Chang, M. S. Shin, H. Y. Yang et al., “Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells,” Biological and Pharmaceutical Bulletin, vol. 29, no. 8, pp. 1597–1602, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. D. R. Green and G. Kroemer, “The pathophysiology of mitochondrial cell death,” Science, vol. 305, no. 5684, pp. 626–629, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Oren, “Decision making by p53: life, death and cancer,” Cell Death and Differentiation, vol. 10, no. 4, pp. 431–442, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. A. J. Butt, S. M. Firth, M. A. King, and R. C. Baxter, “Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells,” Journal of Biological Chemistry, vol. 275, no. 50, pp. 39174–39181, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Miyashita and J. C. Reed, “Tumor suppressor p53 is a direct transcriptional activator of the human bax gene,” Cell, vol. 80, no. 2, pp. 293–299, 1995. View at Google Scholar · View at Scopus
  36. S. P. Cregan, J. G. MacLaurin, C. G. Craig et al., “Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons,” Journal of Neuroscience, vol. 19, no. 18, pp. 7860–7869, 1999. View at Google Scholar · View at Scopus
  37. T. M. Miller, K. L. Moulder, C. M. Knudson et al., “Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death,” Journal of Cell Biology, vol. 139, no. 1, pp. 205–217, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Vekrellis, M. J. McCarthy, A. Watson, J. Whitfield, L. L. Rubin, and J. Ham, “Bax promotes neuronal cell death and is downregulated during the development of the nervous system,” Development, vol. 124, no. 6, pp. 1239–1249, 1997. View at Google Scholar · View at Scopus
  39. I. Martinou, M. Missotten, P. A. Fernandez, R. Sadoul, and J. C. Martinou, “Bax and Bak proteins require caspase activity to trigger apoptosis in sympathetic neurons,” NeuroReport, vol. 9, no. 1, pp. 15–19, 1998. View at Google Scholar · View at Scopus
  40. S. Fulda and K. M. Debatin, “Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy,” Oncogene, vol. 25, no. 34, pp. 4798–4811, 2006. View at Publisher · View at Google Scholar · View at Scopus